Clinical trial Recruiting at 1 site Observational Ages 60 and up

Using femoral vein size to predict low blood pressure after spinal anesthesia in older adults having orthopedic surgery

Official title: Evaluation of Femoral Vein Diameter to Predict Intraoperative Hypotension in Geriatric Patients Undergoing Orthopedic Surgery Under Spinal Anesthesia: A Prospective Observational Study

Run by Cairo University · NCT07339475 · Data updated 2026-11-12

This test will see if the width of the right common femoral vein on ultrasound can predict drops in blood pressure after spinal anesthesia in people over 60 having elective lower-limb orthopedic surgery.

More Spinal Anesthesia trials

Quick facts

Study typeObservational
Ages60 Years and up
SexAll
Enrollment43 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedJuly 1, 2026
Study endsJuly 1, 2026
Registry record updatedJanuary 14, 2026
Trial IDNCT07339475 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults older than 60, ASA physical status I–II, BMI ≤35, scheduled for elective lower-limb orthopedic surgery under spinal anesthesia and willing to undergo a preoperative femoral vein ultrasound.

Probably not a fit

Patients unlikely to benefit include those with BMI >35, contraindications to spinal anesthesia (for example coagulopathy or active infection at the puncture site), emergency surgeries, or those not receiving spinal anesthesia.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will measure the transverse diameter of the right common femoral vein (RCFV) in the inguinal region by ultrasound before spinal anesthesia and track blood pressure changes during elective lower-limb orthopedic operations in patients over 60. Investigators will enroll ASA I–II patients with BMI ≤35 and record perioperative hemodynamics to determine whether a smaller or larger RCFV correlates with post-spinal hypotension. The protocol uses bedside ultrasound as a noninvasive marker of intravascular volume status and compares the RCFV measurement with observed blood pressure drops after spinal block. The work builds on obstetric data and aims to test the method's applicability in a geriatric surgical population.

Why it matters

Potential benefit: If successful, a quick bedside femoral vein ultrasound could help clinicians identify older patients at higher risk of blood pressure drops after spinal anesthesia so they can plan monitoring or preventive measures.

How similar studies have gone: Previous studies—mostly in cesarean delivery populations—have shown promising results using femoral or venous ultrasound measures to predict post-spinal hypotension, but evidence in geriatric orthopedic patients is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 60 years.
* American Society of Anesthesiologists (ASA) physical state I-II.
* Body mass index (BMI) ≤35 kg/m². Patients above this value will be excluded because obesity may cause technical difficulty and poor image quality in femoral vein ultrasound assessment.
* Elective lower-limb orthopedic surgery under spinal anesthesia.

Exclusion Criteria:

* Patients refusing to participate.
* History of psychiatric illness or seizures.
* Absolute contraindications to spinal anesthesia: infection at the puncture site, severe coagulopathy/anticoagulation \[defined as platelet count \<75,000/µL, International Normalized Ratio (INR) \>1.5, Activated Partial Thromboplastin Time (aPTT) \>1.5 times control, or the use of anticoagulants such as warfarin, heparin, low molecular weight heparin, or direct oral anticoagulants within the recommended safety interval for neuraxial anesthesia\], severe hypovolemia, increased intracranial pressure, or known allergy to local anesthetics.
* Severe cardiac disease, including left ventricular ejection fraction \<30%, Severe valvular heart disease (e.g., critical aortic stenosis), clinically significant arrhythmias (atrial fibrillation with uncontrolled ventricular rate \>120 bpm, frequent ventricular ectopy or sustained ventricular tachyarrhythmia) and congestive heart failure such as New York Heart Association (NYHA) class III-IV.
* Severe uncontrolled hypertension, defined as persistent mean arterial pressure (MAP) ≥120 mmHg or systolic blood pressure (SBP) ≥180 mmHg and/or diastolic blood pressure (DBP) ≥110 mmHg despite medical therapy.
* Severe respiratory diseases (Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage III-IV chronic obstructive pulmonary disease, or forced vital capacity (FVC) \<50% predicted).
* Baseline bradycardia (\<50) or mean arterial blood pressure less than 60mmHg.
* Emergency surgeries.

Where it's running

  • Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.